Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Louise Maguire

DipClinPharm, MRPharmS Senior clinical pharmacist for musculoskeletal and dermatology at Newcastle upon Tyne Hospitals NHS Foundation Trust.

Contact Info

Email:
louise.maguire@nuth.ac.uk

Recent stories

  • X-ray of the hip showing femoral neck fracture (James Cavalini/Dreamstime.com)

    Offer a drug holiday from biphosphonates to prevent fracturesSubscription

    2 DEC 2013

    Your patient, a 68-year-old woman, has been taking alendronic acid for five and a half years. She has responded well to the treatment and manages the side effects fairly well. She has not had her therapy reviewed recently and you believe it might be time for a drug holiday. What is the next step?

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.